In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia
Titel:
In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia
Auteur:
Üstün, C. Beksac, M. Dalva, K. Koc, H. Konuk, N. Ilhan, O. Özcan, M. Topcuoglu, P. Sertkaya, D. Hayran, M.